Press release
Autoimmune Hepatitis Treatment Market Size is expected to increase by 2034, estimates DelveInsight
DelveInsight's "Autoimmune Hepatitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Autoimmune Hepatitis, historical and forecasted epidemiology as well as the Autoimmune Hepatitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Unlock detailed insights into the Autoimmune Hepatitis Market by downloading the comprehensive report from DelveInsight @ Autoimmune Hepatitis Therapeutics Market [https://www.delveinsight.com/sample-request/autoimmune-hepatitis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Autoimmune Hepatitis Market Report
* In August 2024:- Novartis Pharmaceuticals- Patients will be randomly assigned to different doses of VAY736 or placebo. The primary analysis is planned at 24 weeks. A subsequent study part will then test the efficacy and safety of VAY736 in a parallel group design. For this part of the trial a new group of autoimmune hepatitis patients will be enrolled.
* In August 2024:- Kezar Life Sciences, Inc.- This is a Phase 2a, multi-center, placebo-controlled study in which patients with autoimmune hepatitis will receive zetomipzomib or placebo in addition to standard-of-care for 24 weeks; an optional open-label extension period allows patients to receive zetomipzomib (KZR-616) for an additional 24 weeks of treatment.
* According to the American Liver Foundation, Autoimmune Hepatitis (AIH) is a disease in which the body's immune system attacks the liver and causes it to become inflamed. The disease is chronic, meaning it lasts many years. If untreated, it can lead to cirrhosis and liver failure.
* It was found that the prevalence of AIH in the US is approximately 31.2 per 100,000 individuals.
* The leading Autoimmune Hepatitis Companies such as Abbott Laboratories, AbbVie, Inc., Arihantanam Life Care Pvt Ltd., AstraZeneca PLC, Bayer AG, Biocon, Ltd., Bio-Rad Laboratories, Inc., Bristol-Myers Squibb Co., Cipla, Ltd., GlaxoSmithKline PLC, Gilead Life sciences, Inc., Johnson & Johnson Services, Inc., Inova Diagnostics, Inc., Merck & Co., Inc., Novartis International AG, Organovo Holdings, Inc., Pfizer, Inc., Upcyte Technologies GmbH, and others.
* Promising Autoimmune Hepatitis Therapies such as VAY736, HR19042 Capsules, zetomipzomib, and others.
Gain a competitive edge in the Autoimmune Hepatitis Market by exploring our in-depth analysis. Visit our website to access the full report and make informed strategic decisions @ Autoimmune Hepatitis Treatment Drugs [https://www.delveinsight.com/sample-request/autoimmune-hepatitis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Autoimmune Hepatitis Epidemiology Segmentation in the 7MM
* Total Autoimmune Hepatitis Prevalent Cases
* Autoimmune Hepatitis Gender-specific Diagnosed Prevalent Cases
* Autoimmune Hepatitis Type-specific Diagnosed Prevalent Cases
* Total Autoimmune Hepatitis Diagnosed Prevalent Cases
* Autoimmune Hepatitis Age-specific Diagnosed Prevalent Cases
* Autoimmune Hepatitis Treated Cases
Autoimmune Hepatitis Market Insights
The goal of treatment of AIH is to stop the body's attack on itself by suppressing the immune system. The basic treatment is the administration of immunosuppressive drugs, the first of which is the oral drug corticosteroid. Medications help to regulate an overactive immune system. Both type 1 and type 2 autoimmune hepatitis are commonly treated with daily doses of the steroid prednisone. Initially, a high dose may be prescribed, which will be gradually reduced as the disease is controlled. The aim is to determine the lowest effective dose that manages the condition.
Discover key developments and opportunities in the Autoimmune Hepatitis Market. Click here to learn more from DelveInsight's latest report @ Autoimmune Hepatitis Market Size [https://www.delveinsight.com/sample-request/autoimmune-hepatitis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Autoimmune Hepatitis Treatment Market Landscape
The Autoimmune Hepatitis treatment market is shifting towards personalized and precision medicine. Efforts are focused on understanding the underlying disease mechanisms to tailor therapies more effectively to individual patients. This includes exploring genetic and molecular profiles to guide treatment decisions and improve outcomes. The emphasis is increasingly on integrating innovative research findings to address the limitations of current treatments and enhance patient care.
Autoimmune Hepatitis Emerging Drugs Profile
* Zetomipzomib (KZR-616): Kezar Life Sciences
* Ianalumab (VAY736): Novartis/MorphoSys
Download DelveInsight's Autoimmune Hepatitis Market report today and stay ahead in this rapidly evolving field. @ Autoimmune Hepatitis Clinical Trials [https://www.delveinsight.com/sample-request/autoimmune-hepatitis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Scope of the Autoimmune Hepatitis Market Report
* Coverage- 7MM
* Autoimmune Hepatitis Companies- Abbott Laboratories, AbbVie, Inc., Arihantanam Life Care Pvt Ltd., AstraZeneca PLC, Bayer AG, Biocon, Ltd., Bio-Rad Laboratories, Inc., Bristol-Myers Squibb Co., Cipla, Ltd., GlaxoSmithKline PLC, Gilead Life sciences, Inc., Johnson & Johnson Services, Inc., Inova Diagnostics, Inc., Merck & Co., Inc., Novartis International AG, Organovo Holdings, Inc., Pfizer, Inc., Upcyte Technologies GmbH, and others.
* Autoimmune Hepatitis Therapies- VAY736, HR19042 Capsules, zetomipzomib, and others.
* Autoimmune Hepatitis Competitive Intelligence Analysis: SWOT analysis and Market entry strategies
* Autoimmune Hepatitis Unmet Needs, KOL's views, Analyst's views, Autoimmune Hepatitis Market Access and Reimbursement
Download the report to understand which factors are driving Autoimmune Hepatitis Market Trends @ Autoimmune Hepatitis Market Trends [https://www.delveinsight.com/sample-request/autoimmune-hepatitis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Table of Content
1. Key Insights
2. Executive Summary of Autoimmune Hepatitis
3. Competitive Intelligence Analysis for Autoimmune Hepatitis
4. Autoimmune Hepatitis: Market Overview at a Glance
5. Autoimmune Hepatitis: Disease Background and Overview
6. Patient Journey
7. Autoimmune Hepatitis Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Autoimmune Hepatitis Unmet Needs
10. Key Endpoints of Autoimmune Hepatitis Treatment
11. Autoimmune Hepatitis Marketed Products
12. Autoimmune Hepatitis Emerging Therapies
13. Autoimmune Hepatitis: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Autoimmune Hepatitis
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=autoimmune-hepatitis-treatment-market-size-is-expected-to-increase-by-2034-estimates-delveinsight]
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Autoimmune Hepatitis Treatment Market Size is expected to increase by 2034, estimates DelveInsight here
News-ID: 3659750 • Views: …
More Releases from ABNewswire
Garden State Consultants Expands Operations with New Office at Cherry Tree Cente …
Garden State Consultants is excited to announce the opening of its newest office location at the Cherry Tree Center in Cherry Hill, NJ.
Cherry Hill, NJ, USA - November 10, 2025 - Garden State Consultants, a fast-growing sales and marketing firm, has announced the opening of its newest office at the Cherry Tree Center in Cherry Hill, NJ. This expansion supports the company's ongoing growth across Camden County and reinforces its…
Eclipse Essence Coffee & Tea Launches Premium Cosmic-Inspired Blends to Transfor …
New beverage brand Eclipse Essence Coffee & Tea debuts with premium small-batch blends like Vanilla Aurora and Lunar Roast, designed to elevate morning routines into mindful rituals. The company combines craft coffee culture with spiritual wellness to create intentional drinking experiences.
Eclipse Essence Coffee & Tea emerges as a revolutionary force in the specialty beverage industry, introducing a unique philosophy that transforms the simple act of drinking coffee or tea into…
Yaya Skincare Revolutionizes Teen Skincare Market with Barrier-Strengthening For …
Yaya Skincare launches a groundbreaking skincare line specifically formulated for teens, tweens, and young adults, rejecting harsh anti-aging actives in favor of clean, barrier-strengthening ingredients. The brand, recently featured on CBS NY's The Donna Drake Show, offers dermatologist-recommended products that champion the philosophy that consistent, early care is the new foundation for lifelong skin health.
Yaya Skincare enters the beauty market with a revolutionary approach to teenage and young adult skincare,…
From the Football Field to the Family Legacy: How a London Son Turned Loss into …
When his father fell ill, McMaster University running back Cameron Guest traded his cleats for a chisel - building Forest City Memorials to honour his dad and change how London families experience loss.
When his father fell ill, McMaster University running back Cameron Guest traded hiscleats for a chisel - building Forest City Memorials to honour his dad and change howLondon families experience loss.
When Cameron Guest was playing football at McMaster…
More Releases for Autoimmune
Autoimmune Polyglandular Syndrome Market analysis reveals CAGR of 6.20 percent t …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Autoimmune Polyglandular Syndrome Type 1 Market - (By Diagnosis (Serum Autoimmune Screen, End-organ Function Tests, Blood Tests, Others), Age of Onset (Childhood, Adult, Adolescent), Treatment (Medication, Hormone Replacement Therapy, Others), Dosage Form (Tablet, Capsule, Others), Route of Administration (Oral, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others)),…
Reshaping Autoimmune Therapy Landscape: Protheragen Announces Small Molecule Dru …
Protheragen announced its comprehensive small molecule drug development services aimed at advancing innovative therapies for a range of autoimmune diseases.
New York, USA - Protheragen announced its comprehensive small molecule drug development services aimed at advancing innovative therapies for a range of autoimmune conditions. From target identification to preclinical studies, Protheragen leverages its expertise in small molecule drug design and development to offer tailored services that provide biotech and pharmaceutical companies…
Autoimmune Disease Diagnosis Market - Strength in Knowledge, Defying Autoimmune …
Newark, New Castle, USA: The "Autoimmune Disease Diagnosis Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Autoimmune Disease Diagnosis Market: https://www.growthplusreports.com/report/autoimmune-disease-diagnosis-market/7616
This latest report researches the industry structure,…
Autoimmune Drugs Market: Understanding How They Work and Their Importance in Tre …
Allied Market Research recently said Autoimmune diseases are a group of disorders in which the body's immune system attacks its own healthy tissues, mistaking them for foreign invaders. These diseases can affect any part of the body, including the joints, skin, and organs. They can be debilitating, chronic, and sometimes life-threatening. Autoimmune drugs are medications that help to suppress or modulate the immune system's response to prevent it from attacking…
Autoimmune Disease Diagnostics Market: Growing Awareness among People about Auto …
According to the recent report by Transparency Market Research, the global autoimmune disease diagnostics market has a highly consolidated scenario. The market is dominated by a handful of players. However, these players have a stronghold over the dynamics of market and pose a great challenge for any new entrant to set its foot in the market.
Read Report Overview - https://www.transparencymarketresearch.com/autoimmune-disease-diagnostics-market.html
To reduce effects of such hindrances, the new entrants are…
Autoimmune Disease Therapeutics Market Boost due to increase in incidence of aut …
According to a new report published by Allied Market Research, titled,"Autoimmune Disease Therapeutics Market by Drug Class, Indication, and Sales Channel: Global Opportunity Analysis and Industry Forecast, 2018 - 2025," the global autoimmune disease therapeutics market was valued at $109,833 million in 2017, and is expected to reach $153,320 million by 2025, growing at a CAGR of 4.2% from 2018 to 2025.
Download the Sample Report @ https://www.alliedmarketresearch.com/request-sample/5185?utm_source=openpr&utm_medium=Niranjan
Autoimmune disease therapeutics include…
